Cholera Global Clinical Trials Review, H2, 2016

Cholera Global Clinical Trials Review, H2, 2016


  • Products Id :- GDHC3978CTIDB
  • |
  • Pages: 62
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cholera Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, "Cholera Global Clinical Trials Review, H2, 2016" provides an overview of Cholera clinical trials scenario. This report provides top line data relating to the clinical trials on Cholera. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12

Top Countries Contributing to Clinical Trials in Central and South America 13

Clinical Trials by G7 Countries: Proportion of Cholera to Infectious Disease Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Cholera to Infectious Disease Clinical Trials 17

Clinical Trials in E7 Countries by Trial Status 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Subjects Recruited Over a Period of Time 23

Clinical Trials by Sponsor Type 24

Prominent Sponsors 25

Top Companies Participating in Cholera Therapeutics Clinical Trials 26

Prominent Drugs 28

Clinical Trial Profile Snapshots 29

Appendix 59

Abbreviations 59

Definitions 59

Research Methodology 60

Secondary Research 60

About GlobalData 61

Contact Us 61

Disclaimer 61

Source 62

List of Figures

Cholera Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Cholera Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Cholera Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Cholera Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9

Cholera Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 10

Cholera Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

Cholera Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12

Cholera Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13

Proportion of Cholera to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14

Cholera Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Cholera Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Cholera to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17

Cholera Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18

Cholera Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19

Cholera Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20

Cholera Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

Cholera Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22

Cholera Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

Cholera Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24

Cholera Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

Cholera Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26

Cholera Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

GlobalData Methodology 60

List of Tables

Cholera Therapeutics, Global, Clinical Trials by Region, 2016* 6

Cholera Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Cholera Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Cholera Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9

Cholera Therapeutics Clinical Trials, Europe, Top Countries, 2016* 10

Cholera Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Cholera Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12

Cholera Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13

Proportion of Cholera to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14

Cholera Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Cholera Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Cholera to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17

Cholera Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18

Cholera Therapeutics, Global, Clinical Trials by Phase, 2016* 19

Cholera Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20

Cholera Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

Cholera Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22

Cholera Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

Cholera Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24

Cholera Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

Cholera Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Cholera Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

International Centre for Diarrhoeal Disease Research Bangladesh, Sanofi, PaxVax Inc, Eubiologics Co Ltd, QPS Holdings LLC, NIZO food research BV, MSD Wellcome Trust Hilleman Laboratories Pvt Ltd, Jean Brown Research, FrieslandCampina Innovation International, Avail Clinical Research LLC

Cholera Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Cholera, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 168625
Site License
USD 5000 INR 337250
Corporate User License
USD 7500 INR 505875

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com